Bitte aktiviere Javascript und schalte etwaige Werbeblocker ab

Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

West Pharmaceutical Services Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

West Pharmaceutical Services Q2 Earnings Call Highlights

Key Points

Interested in West Pharmaceutical Services, Inc.? Here are five stocks we like better.

West Pharmaceutical Services beat second-quarter expectations, with revenue up 13% organically

0

Bayer Aktie: Prostatakrebs-Partnerschaft mit KairosPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Bayer Aktie: Prostatakrebs-Partnerschaft mit Kairos

Bayer sorgt mit einer neuen Onkologie-Partnerschaft für Aufmerksamkeit, während aus den USA zugleich eine…

Der Beitrag Bayer Aktie: Prostatakrebs-Partnerschaft mit Kairos erschien zuerst auf kapital

0

Corporacion Inmobiliaria Vesta Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

Corporacion Inmobiliaria Vesta Q2 Earnings Call Highlights

Key Points

Interested in Corporacion Inmobiliaria Vesta, S.A.B. de C.V. Sponsored ADR? Here are five stocks we like better.

Second-quarter performance improved as Vesta reported revenue up

0

Columbia Banking System Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Columbia Banking System Q2 Earnings Call Highlights

Key Points

Interested in Columbia Banking System, Inc.? Here are five stocks we like better.

Columbia Banking System beat expectations on profitability and fees, reporting Q2 EPS of $0.73 and

0

SS&C Technologies Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

SS&C Technologies Q2 Earnings Call Highlights

Key Points

Interested in SS&C Technologies Holdings, Inc.? Here are five stocks we like better.

SS&C Technologies posted record second-quarter 2026 results, with adjusted revenue up 10.3% to

0

AtriCure Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

AtriCure Q2 Earnings Call Highlights

Key Points

Interested in AtriCure, Inc.? Here are five stocks we like better.

AtriCure posted strong Q2 2026 results, with revenue up 12.8% to $153.6 million and a return to GAAP

0

Molina Healthcare Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Molina Healthcare Q2 Earnings Call Highlights

Key Points

Interested in Molina Healthcare, Inc? Here are five stocks we like better.

Molina Healthcare beat second-quarter expectations with adjusted EPS of $1.51 on $10.2 billion of premium

0

Quest Diagnostics Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Quest Diagnostics Q2 Earnings Call Highlights

Key Points

Interested in Quest Diagnostics Incorporated? Here are five stocks we like better.

Quest Diagnostics posted strong Q2 results, with revenue up 10.2% to $3.04 billion and adjusted

0

Community Health Systems Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Community Health Systems Q2 Earnings Call Highlights

Key Points

Interested in Community Health Systems, Inc.? Here are five stocks we like better.

Community Health Systems cut its full-year 2026 outlook after second-quarter results came in below

0

FirstService Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

FirstService Q2 Earnings Call Highlights

Key Points

Interested in FirstService Corporation? Here are five stocks we like better.

FirstService posted modest Q2 growth, with revenue up 2% year over year to $1.45 billion, adjusted

0

Organon & Co. Shareholders Clear Sun Pharma Merger DealPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Organon & Co. Shareholders Clear Sun Pharma Merger Deal

Key Points

Interested in Organon & Co.? Here are five stocks we like better.

Organon shareholders approved the company’s proposed merger with Sun Pharmaceutical Holdings USA, clearing a major

0

AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip BattlePhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle

Key Points

Interested in Advanced Micro Devices, Inc.? Here are five stocks we like better.

AMD and Anthropic announced a strategic partnership tied to up to 2 gigawatts of AMD Instinct MI450

0

T-Mobile US Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

T-Mobile US Q2 Earnings Call Highlights

Key Points

Interested in T-Mobile US, Inc.? Here are five stocks we like better.

Strong Q2 operating performance: T-Mobile said it had an “extraordinary” quarter, adding 277,000 postpaid net

0

Sartorius Aktiengesellschaft Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Sartorius Aktiengesellschaft Q2 Earnings Call Highlights

Key Points

Interested in Sartorius Aktiengesellschaft? Here are five stocks we like better.

Sartorius reported solid first-half growth, with constant-currency sales up 7.7% and underlying

0

EQS-News: Gerresheimer nimmt neues Werk in Zhenjiang Dagang, China, in BetriebPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

EQS-News: Gerresheimer nimmt neues Werk in Zhenjiang Dagang, China, in Betrieb

EQS-News: Gerresheimer nimmt neues Werk in Zhenjiang Dagang, China, in Betrieb

0

EQS-News: Fresenius gründet Venture-Fonds mit mindestens 200 Millionen Euro und treibt Innovationen im Gesundheitswesen voranPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

EQS-News: Fresenius gründet Venture-Fonds mit mindestens 200 Millionen Euro und treibt Innovationen im Gesundheitswesen voran

EQS-News: Fresenius gründet Venture-Fonds mit mindestens 200 Millionen Euro und treibt Innovationen im Gesundheitswesen voran

0

EQS-News: Sartorius setzt positive Dynamik fort und wächst weiter profitabel: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us

EQS-News: Sartorius setzt positive Dynamik fort und wächst weiter profitabel

EQS-News: Sartorius setzt positive Dynamik fort und wächst weiter profitabel

0

[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche setzt starke Dynamik in erstem Halbjahr 2026 mit Umsatzwachstum von +6% zu konstanten Wechselkursen fort; -2% in CHF aufgrund deutlicher Aufwertung des Schweizer FrankensPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche setzt starke Dynamik in erstem Halbjahr 2026 mit Umsatzwachstum von +6% zu konstanten Wechselkursen fort; -2% in CHF aufgrund deutlicher Aufwertung des Schweizer Frankens

Konzernverkäufe stiegen in den ersten sechs Monaten um 6% zu konstanten Wechselkursen (CER¹; in CHF ausgewiesen -2% und auf USD-Basis² 8%) aufgrund hoher Nachfrage nach innovativen Medikamenten

0

[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche setzt starke Dynamik in erstem Halbjahr 2026 mit Umsatzwachstum von +6% zu konstanten Wechselkursen fort; -2% in CHF aufgrund deutlicher Aufwertung des Schweizer FrankensPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche setzt starke Dynamik in erstem Halbjahr 2026 mit Umsatzwachstum von +6% zu konstanten Wechselkursen fort; -2% in CHF aufgrund deutlicher Aufwertung des Schweizer Frankens

Konzernverkäufe stiegen in den ersten sechs Monaten um 6% zu konstanten Wechselkursen (CER¹; in CHF ausgewiesen -2% und auf USD-Basis² 8%) aufgrund hoher Nachfrage nach innovativen Medikamenten

0

Bayer Aktie: Ruveon zieht 446-Prozent-Zollantrag zurückPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Bayer Aktie: Ruveon zieht 446-Prozent-Zollantrag zurück

Bayer vollzieht in dieser Woche einen bemerkenswerten Rückzieher. Der Konzern zieht einen umstrittenen Zollantrag…

Der Beitrag Bayer Aktie: Ruveon zieht 446-Prozent-Zollantrag zurück erschien zuerst

0

Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA AlignmentPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA Alignment

Key Points

Interested in Ocular Therapeutix, Inc.? Here are five stocks we like better.

Ocular Therapeutix says it remains on track to file an NDA for AXPAXLI in wet age-related macular

0

Knight-Swift Transportation Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Knight-Swift Transportation Q2 Earnings Call Highlights

Key Points

Interested in Knight-Swift Transportation Holdings Inc.? Here are five stocks we like better.

Knight-Swift said the truckload market tightened sharply in Q2 2026, with spot rates

0

Crown Castle Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Crown Castle Q2 Earnings Call Highlights

Key Points

Interested in Crown Castle Inc.? Here are five stocks we like better.

Crown Castle reported solid Q2 2026 results and raised full-year guidance, lifting both site rental revenue and

0

Belite Bio Conference Highlights Tinlarebant Data and New Hope for Retinal DiseasesPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

Belite Bio Conference Highlights Tinlarebant Data and New Hope for Retinal Diseases

Key Points

Interested in Belite Bio, Inc. Sponsored ADR? Here are five stocks we like better.

Belite Bio highlighted positive tinlarebant data from its DRAGON trial in Stargardt disease

0

Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy ReachPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach

Key Points

Interested in Repligen Corporation? Here are five stocks we like better.

Repligen is acquiring BioLife Solutions in a deal valued at about $1.5 billion, paying $31 per share in a

0

Vorherige Nächste